Literature DB >> 1694179

Beta protein C is not glycosylated at asparagine 329. The rate of translation may influence the frequency of usage at asparagine-X-cysteine sites.

J P Miletich1, G J Broze.   

Abstract

About 30% of human plasma protein C is smaller than the predominant form as judged by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. It has been suggested that this species, referred to as beta protein C, is a degraded molecule. However, beta protein C is secreted in culture by the HepG2 cell line and is present in plasma collected directly into numerous proteinase inhibitors; the percentage of beta protein C does not change with time during culture or after blood collection. Neither thrombin, activated protein C, nor activated factor X converts the alpha form to beta in the presence or absence of calcium and phospholipids. The NH2-terminal sequences of the heavy chains of both forms are identical, and both release the same dodecapeptide and develop a functional active site when cleaved by thrombin. Both also react with antibodies to a synthetic COOH-terminal peptide. Timed digests with N-glycosidase are consistent with the interpretation that beta protein C has three N-linked oligosaccharide chains whereas alpha protein C has four. It is asparagine 329 that is not glycosylated in beta protein C since antibodies to a synthetic peptide based on the sequence around this amino acid react only with beta protein C. This site is unique in having cysteine instead of serine or threonine 2 residues distal. It is likely that the sulfhydryl group can substitute for the usual hydroxyl group as a hydrogen bond acceptor for the glycosylation reaction only until it forms a disulfide bond. The percentage of protein C that is glycosylated at this site may therefore depend at least in part on the rate of disulfide bond formation which may in turn be related to the rate of protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1694179

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Structural requirements of human DNase II alpha for formation of the active enzyme: the role of the signal peptide, N-glycosylation, and disulphide bridging.

Authors:  Kyle S MacLea; Ronald J Krieser; Alan Eastman
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

2.  Exposure of R169 controls protein C activation and autoactivation.

Authors:  Nicola Pozzi; Sergio Barranco-Medina; Zhiwei Chen; Enrico Di Cera
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

3.  Activated protein C N-linked glycans modulate cytoprotective signaling function on endothelial cells.

Authors:  Fionnuala Ní Ainle; James S O'Donnell; Jennifer A Johnson; Laura Brown; Eimear M Gleeson; Owen P Smith; Roger J S Preston
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

4.  Activation of protein C by the thrombin-thrombomodulin complex: cooperative roles of Arg-35 of thrombin and Arg-67 of protein C.

Authors:  Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-17       Impact factor: 11.205

5.  Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine.

Authors:  S R Lentz; J E Sadler
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

6.  Identification of Novel N-Glycosylation Sites at Noncanonical Protein Consensus Motifs.

Authors:  Mark S Lowenthal; Kiersta S Davis; Trina Formolo; Lisa E Kilpatrick; Karen W Phinney
Journal:  J Proteome Res       Date:  2016-06-14       Impact factor: 4.466

Review 7.  Oligosaccharyltransferase: the central enzyme of N-linked protein glycosylation.

Authors:  Elisabeth Mohorko; Rudi Glockshuber; Markus Aebi
Journal:  J Inherit Metab Dis       Date:  2011-05-26       Impact factor: 4.982

8.  Targeted gene sequencing identifies variants in the protein C and endothelial protein C receptor genes in patients with unprovoked venous thromboembolism.

Authors:  Cynthia Wu; Dhruva J Dwivedi; Laura Pepler; Zakhar Lysov; John Waye; Jim Julian; Karl Desch; David Ginsburg; Jeffrey I Weitz; Clive Kearon; Patricia C Liaw
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-09-19       Impact factor: 8.311

9.  Refined topology model of the STT3/Stt3 protein subunit of the oligosaccharyltransferase complex.

Authors:  Patricia Lara; Karin Öjemalm; Johannes Reithinger; Aurora Holgado; You Maojun; Abdessalem Hammed; Daniel Mattle; Hyun Kim; IngMarie Nilsson
Journal:  J Biol Chem       Date:  2017-05-16       Impact factor: 5.157

10.  Cell-free synthesis of enzymically active tissue-type plasminogen activator. Protein folding determines the extent of N-linked glycosylation.

Authors:  N J Bulleid; R S Bassel-Duby; R B Freedman; J F Sambrook; M J Gething
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.